Schott Pharma AG & CO KGaA annual shareholders’ equity
2020
2021
2022
2023
2024
2025
Schott Pharma AG & CO KGaA Shareholders’ Equity Growth & History (1SXP)
Schott Pharma AG & CO KGaA's shareholders’ equity was €891.8M for fiscal 2025.
View full Schott Pharma AG & CO KGaA company overviewSchott Pharma AG & CO KGaA annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | €891.8M | €105.2M | +13.37% |
| 2024 | 2024-09-30 | €786.6M | €96.2M | +13.93% |
| 2023 | 2023-09-30 | €690.4M | −€16.8M | −2.38% |
| 2022 | 2022-09-30 | €707.3M | €289.3M | +69.22% |
| 2021 | 2021-09-30 | €418.0M | €103.4M | +32.89% |
| 2020 | 2020-09-30 | €314.5M | — | — |
Schott Pharma AG & CO KGaA quarterly shareholders’ equity
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | €996.1M | €132.9M | +15.39% |
| Q2 2026 | 2026-03-31 | €942.2M | €105.6M | +12.62% |
| Q1 2026 | 2025-12-31 | €930.2M | — | — |
| Q4 2025 | 2025-09-30 | €891.8M | — | — |
| Q3 2025 | 2025-06-30 | €863.3M | — | — |
| Q2 2025 | 2025-03-31 | €836.7M | — | — |
Schott Pharma AG & CO KGaA shareholders’ equity trends
Over the last five fiscal years, Schott Pharma AG & CO KGaA's shareholders’ equity increased from €314.5M to €891.8M, a change of €577.3M. The latest reported quarter, Q3 2026, shows €996.1M.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company official filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Schott Pharma AG & CO KGaA source filings ↗